Loading search results
The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States
Sponsor study identifier
Secondary identifiers
observational
20,169
1 country
1
Study Start
February 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
This study will investigate patterns of Kaposi's sarcoma herpes virus (KSHV) in the United States and its potential impact on the U.S. population. KSHV is a newly discovered virus that is strongly associated with Kaposi's sarcoma and primary effusion lymphoma. The high prevalence of KS and KSHV among HIV-infected homosexual men suggests sexual contact as a primary mode of transmission. Reports of non-sexual transmission in parts of Africa and the Mediterranean where Kaposi's sarcoma is endemic, and the identification of viral DNA in saliva and other bodily fluids, however, indicate the virus is also transmitted non-sexually. This study will:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2001
Date type not reportedThis date has not been verified as actual or estimated.
November 14, 2001
Actual (reported)November 15, 2001
Actual (reported)December 2005
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
National Cancer Institute (NCI)
Bethesda, Maryland, 20892, United States
Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet. 1995 Mar 25;345(8952):759-61. doi: 10.1016/s0140-6736(95)90641-x.
First Submitted
November 14, 2001
First Posted
November 15, 2001
Study Start
February 2001
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
December 2005
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
March 4, 2008
Record last verified: 2005-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: